Nicholas Investment Partners, LP Roivant Sciences Ltd. Transaction History

Nicholas Investment Partners, LP

  • $845 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$8.38 - $11.58 $23.8 Million - $32.9 Million
-2,840,120 Reduced 94.73%
158,015 $1.77 Million
Q3 2023

Nov 13, 2023
BUY
$9.76 - $13.19 $7.15 Million - $9.67 Million
732,812 Added 32.35%
2,998,135 $35 Million
Q2 2023

Aug 09, 2023
BUY
$7.09 - $10.08 $8.46 Million - $12 Million
1,192,940 Added 111.24%
2,265,323 $22.8 Million
Q1 2023

May 11, 2023
BUY
$6.92 - $9.98 $7.42 Million - $10.7 Million
1,072,383 New
1,072,383 $7.91 Million

Others Institutions Holding ROIV

# of Institutions
308
Shares Held
496M
Call Options Held
989K
Put Options Held
1.15M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.49B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email